Work

Supplementary Figure S3 from Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3–Expressing Hepatocellular Carcinoma

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Figure S3: GPC3-specific targeting peptide has a similar binding pattern to HCC samples compared to immunostaining with GPC3 antibody. (A-D) Representative contiguous slides from HCC samples stained with GPC3 antibody (A, B) and GPC3-specific peptide (C, D) demonstrate similar staining patterns. HCC, hepatocellular carcinoma.

DOI: 10.1158/1535-7163.27951220

Authors: Peiman Habibollahi, Alexey Gurevich, James Z. Hui, Kelly Weinfurtner, George McClung, Justin Adler, Michael C. Soulen, David E. Kaplan, Gregory J. Nadolski, Stephen J. Hunt, Andrew Tsourkas, Terence P. Gade

Language: English

Topic: Nanoplatforms for cancer theranostics

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4404976146

Cites:

Cited by:

Related to: 10